These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 18677519)

  • 1. Prognostic value of procalcitonin in Legionella pneumonia.
    Haeuptle J; Zaborsky R; Fiumefreddo R; Trampuz A; Steffen I; Frei R; Christ-Crain M; Müller B; Schuetz P
    Eur J Clin Microbiol Infect Dis; 2009 Jan; 28(1):55-60. PubMed ID: 18677519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Procalcitonin kinetics in Legionella pneumophila pneumonia.
    de Jager CP; de Wit NC; Weers-Pothoff G; van der Poll T; Wever PC
    Clin Microbiol Infect; 2009 Nov; 15(11):1020-5. PubMed ID: 19438643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can we predict pneumococcal bacteremia in patients with severe community-acquired pneumonia?
    Pereira JM; Teixeira-Pinto A; Basílio C; Sousa-Dias C; Mergulhão P; Paiva JA
    J Crit Care; 2013 Dec; 28(6):970-4. PubMed ID: 24216331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia.
    Müller B; Harbarth S; Stolz D; Bingisser R; Mueller C; Leuppi J; Nusbaumer C; Tamm M; Christ-Crain M
    BMC Infect Dis; 2007 Mar; 7():10. PubMed ID: 17335562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical predictors for Legionella in patients presenting with community-acquired pneumonia to the emergency department.
    Fiumefreddo R; Zaborsky R; Haeuptle J; Christ-Crain M; Trampuz A; Steffen I; Frei R; Müller B; Schuetz P
    BMC Pulm Med; 2009 Jan; 9():4. PubMed ID: 19152698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy of C-reactive protein, procalcitonin, and mid-regional pro-atrial natriuretic peptide to guide site of care of community-acquired pneumonia.
    Claessens YE; Mathevon T; Kierzek G; Grabar S; Jegou D; Batard E; Loyer C; Davido A; Hausfater P; Robert H; Lavagna-Perez L; Bernot B; Plaisance P; Leroy C; Renaud B
    Intensive Care Med; 2010 May; 36(5):799-809. PubMed ID: 20232049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of procalcitonin in community-acquired pneumonia.
    Schuetz P; Suter-Widmer I; Chaudri A; Christ-Crain M; Zimmerli W; Mueller B;
    Eur Respir J; 2011 Feb; 37(2):384-92. PubMed ID: 20595156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic and prognostic values of admission procalcitonin levels in community-acquired pneumonia in an intensive care unit.
    Boussekey N; Leroy O; Georges H; Devos P; d'Escrivan T; Guery B
    Infection; 2005 Aug; 33(4):257-63. PubMed ID: 16091896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnostic value of serum procalcitonin in identifying the etiology of non-responding community-acquired pneumonia after initial antibiotic therapy].
    Wang Z; Zhang X; Wu J; Zhang W; Kuang H; Li X; Xuan W; Wang K; Ma L
    Zhonghua Jie He He Hu Xi Za Zhi; 2014 Nov; 37(11):824-30. PubMed ID: 25604112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of a diagnostic score model for the prediction of Legionella pneumophila pneumonia.
    Miyashita N; Horita N; Higa F; Aoki Y; Kikuchi T; Seki M; Tateda K; Maki N; Uchino K; Ogasawara K; Kiyota H; Watanabe A
    J Infect Chemother; 2019 Jun; 25(6):407-412. PubMed ID: 30935766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical potential of C-reactive protein and procalcitonin serum concentrations to guide differential diagnosis and clinical management of pneumococcal and Legionella pneumonia.
    Bellmann-Weiler R; Ausserwinkler M; Kurz K; Theurl I; Weiss G
    J Clin Microbiol; 2010 May; 48(5):1915-7. PubMed ID: 20220163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes.
    Krüger S; Ewig S; Marre R; Papassotiriou J; Richter K; von Baum H; Suttorp N; Welte T;
    Eur Respir J; 2008 Feb; 31(2):349-55. PubMed ID: 17959641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive values of semi-quantitative procalcitonin test and common biomarkers for the clinical outcomes of community-acquired pneumonia.
    Ugajin M; Yamaki K; Hirasawa N; Yagi T
    Respir Care; 2014 Apr; 59(4):564-73. PubMed ID: 24170911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of two biomarkers for directing care among patients with non-severe community-acquired pneumonia.
    España PP; Capelastegui A; Bilbao A; Diez R; Izquierdo F; Lopez de Goicoetxea MJ; Gamazo J; Medel F; Salgado J; Gorostiaga I; Quintana JM;
    Eur J Clin Microbiol Infect Dis; 2012 Dec; 31(12):3397-405. PubMed ID: 23010902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multinational, observational study of procalcitonin in ICU patients with pneumonia requiring mechanical ventilation: a multicenter observational study.
    Bloos F; Marshall JC; Dellinger RP; Vincent JL; Gutierrez G; Rivers E; Balk RA; Laterre PF; Angus DC; Reinhart K; Brunkhorst FM
    Crit Care; 2011; 15(2):R88. PubMed ID: 21385367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The diagnostic value of different pro-inflammatory factor in early diagnosis of sepsis in patients with bloodstream infection].
    Chen W; Zhao L; Niu S; Wang S; Sheng B; Zhen J; Gu X; Lyu C
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Mar; 26(3):165-70. PubMed ID: 24598289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers improve mortality prediction by prognostic scales in community-acquired pneumonia.
    Menéndez R; Martínez R; Reyes S; Mensa J; Filella X; Marcos MA; Martínez A; Esquinas C; Ramirez P; Torres A
    Thorax; 2009 Jul; 64(7):587-91. PubMed ID: 19131448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of procalcitonin for differentiating cryptogenic organising pneumonia from community-acquired pneumonia.
    Ito A; Ishida T; Tachibana H; Arita M; Yamazaki A; Washio Y
    Clin Chem Lab Med; 2019 Sep; 57(10):1632-1637. PubMed ID: 31120857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of pro-adrenomedullin for identifying adverse outcomes in community-acquired pneumonia.
    España PP; Capelastegui A; Mar C; Bilbao A; Quintana JM; Diez R; Esteban C; Bereciartua E; Unanue U; Uranga A
    J Infect; 2015 May; 70(5):457-66. PubMed ID: 25499199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of a semi-quantitative procalcitonin test and the A-DROP Japanese prognostic scale for predicting mortality among adults hospitalized with community-acquired pneumonia.
    Kasamatsu Y; Yamaguchi T; Kawaguchi T; Tanaka N; Oka H; Nakamura T; Yamagami K; Yoshioka K; Imanishi M
    Respirology; 2012 Feb; 17(2):330-6. PubMed ID: 22059525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.